The sedation and subsequent recovery following administration of three formulations of diazepam (propylene glycol, mixed micelle and lipid emulsion) were compared in a randomised, double-blind, crossover study of twelve male volunteers. Following intravenous injections of 10 mg of each formulation, sedation was assessed for ten minutes using a six-point ordinal sedation score and subsequent recovery was assessed using a psychomotor/sedation battery including simple reflex time, letter deletion test, a simple arithmetic exercise, digit recall and a linear analogue sedation scale.
With the introduction of two new parenteral diazepam formulations, Diazemuls (Kabi Vitrum) and Valium Mixed Micelle (Roche), the incidence of these sideeffects has been reduced almost tenfold. Diazemuls 2 ,4,5 uses the same medium as di-isopropylphenol (Propofol, ICI), where the drug is solubilised in lipid and then formulated as an emulsion. In Valium Mixed Micelle, diazepam is held in complexes of bile acids and lecithin. 6 ,7 The complexes formed are virtually identical to those found physiologically to dissolve lipid soluble substances such as cholesterol. 8 Clinical studies suggest that these new preparations are less potent that the standard propylene glycol formulation. 7 ,9 The aim of this present study in volunteers was to determine the effect these solvent systems had produced on the sedation and subsequent recovery after the administration of diazepam intravenously. METHODS The study was performed on twelve male volunteers aged 22 to 28 years. All were healthy, on no regular psychotropic medications and had been asked to refrain from ingesting alcohol for 24 hours, or coffee for six hours, prior to the study period. Informed consent was obtained from each subject and local ethical committee approval obtained.
On each of three study days an 18-gauge cannula was inserted into an antecubital fossa vein in the non-dominant arm and an infusion of normal physiological saline begun at a constant rate. The volunteers then received as a rapid bolus injection, into the running infusion, 10 mg of either diazepam in propylene glycol (DPG), diazepam as a lipid emulsion (DLE) or diazepam mixed micelle (DMM) according to a random order, latin square, crossover design. Injections were prepared and given by an anaesthetist not involved with data collection and were made double blind by the masking of the syringe barrel and IV tubing. The use of the antecubital fossa and injection into a running infusion were chosen to reduce the unblinding effect of pain caused by the propylene glycol formulation. Each study day was separated by an interval of at least three weeks. All measurements were made under similar ambient conditions of temperature and light intensity and all data were recorded by the same investigator.
During the first ten minutes following injection, subjects lay supine and were asked to keep their eyes open, blinking as required but not to talk. The observed degree of sedation was recorded using a six-point scoring system (Table 1) based upon eye signs and response to stimulation. Throughout the ten minute observation period, variations in the sedation score were input directly by the observer onto a microcomputer with timing function.
Heart rate, blood pressure (Dinamap automatic recorder), respiratory rate, end tidal carbon dioxide (nasal cannulae with Datex C02 analyser) and oxygen saturation (Biox ear oximeter) were recorded at one minute intervals for the first ten minutes. Prior to drug administration and at times 10, 30, 60, 120 and 180 minutes following injection, each subject performed a psychomotor/sedation test battery (see below). Before beginning the study and at the commencement of each study day, a short training period was given to each subject in order to reduce the element of learning. Psychomotor/Sedation test battery 1, Linear analogue sedation scale. Subjects were asked to assess their degree of sedation by marking a 10 cm linear analogue scale, the extremes of which were denoted 'wide awake, alert' (0 cm) and 'drowsy, dull' (10 cm).
2. Letter deletion test. Thirty lines of 25 randomly typed upper and lower case letters were given for subjects to delete as many letters g or G in a two minute time interval as possible.
3. Reflex Time. Simple reflex time was assessed as the time taken to depress a button following a visual light stimulus. The mean reflex time was taken as the mean value for the last 30 of 35 attempts.
4. Simple Arithmetic. Twenty-five pairs of two-digit numbers were presented on a microcomputer screen for addition, each requiring an answer to be given within a fivesecond interval. The psychomotor score was taken as the number of correct responses.
5. Seven-digit recall. Thirty consecutive seven-digit numbers were presented on a microcomputer screen for recall. Each number was shown to the subject for four seconds and, after a seven-second interval, subjects entered the memorised number onto the keyboard. The digit recall score was taken as the total number of digits recalled out of the possible 210.
Reflex time, simple arithmetic and sevendigit recall were each performed on an Apple lIe microcomputer.
Statistical analysis
Between-group comparisons of physiological variables were analysed using a three way (drug, time, study day) analysis of variance (ANOV A) for repeated measures.
For the changes in sedation score over the first ten minutes, the ordinal six-point sedation scale was converted, for each subject, at thirty-second intervals, into a rank order of sedation (1 to 3 for each study day) according to the comparative degree of sedation produced by each drug on that individual. Means were taken for tied ranks and these ranks were then compared for each drug using a three-factor (drug, time and study day) ANOV A for repeated measures and, if significant between group differences were found, individual time points were compared using a two-factor ANOVA (drug, study day).
The changes in each of the psychomotor/ sedation tests were analysed using a threefactor (drug, time and study day) ANOVA for repeated measures.
All analyses were performed using a Statview 512 package and Apple Macintosh SE microcomputer.
RESULTS
Anthropometric data is shown in Table 2 . Following injection, no significant betweendrug difference was found for the physiological variables heart rate, blood pressure, end tidal C02, oxygen saturation or respiratory rate. Figure 1 shows the mean values of the ordinal sedation score for the three formulations during the first ten minutes following administration.
Repeated measure ANOV A of ranked potency showed a difference between the ranked order of potency between drugs (P = 0.007) with DPG ranked significantly more potent over the ten minute periods than DMM (P= 0.014) or DLE (P= 0.005). There was also a significant change according to study day (P = 0.016) with an increasing level of ranked potency with each subsequent day.
In addition a significant drug x time (P = 0.002) and study day x time (P < 0.0001) interaction was found. Comparison at each thirty-second interval by a two-factor (drug, study day) ANOVA of ranked potency revealed a significantly greater potency for DPG over DLE from 2 to 4 and 5 to 6.5 minutes and for DPG over DMM from 4 to 6.5, 8 to 8.5 and 9.5 to 10 minutes deletion test and visual analogue sedation score over the four-hour recovery period. For each test, summaries of P values derived from their repeated measures ANOV A is given in Table 3 .
Each test showed a highly significant variation with time, but none showed a significant between-drug variation or drug x time interation. Reflex time showed a significant (P = 0.033) increasing, betweenstudy day variation, and for all tests the level of significance for changes with study day was greater than that for drug. Thus, rather than the recovery profile varying between the three formulations, there was a tendency towards poorer performance with each progressive study day independent of the drug administered. DISCUSSION An ideal solvent would be nontoxic, would exert no pharmacological effects of its own and would not interfere with drug disposition. 6 In this study we examined the effect of three solvent systems on the sedative efficacy and subsequent recovery from intravenous diazepam.
Clinical studies have suggested that a difference does exist in the efficacy of diazepam formulations 7 • 1o indicating a lower potency for lipid emulsion and mixed micelle solvents in comparison with the standard propylene glycol solution.
In an unpublished crossover study of six volunteers (Roche -data on file), no significant difference in elimination half-life, steady-state distribution volume or mean plasma clearance was found between DPG, DLE and DMM. In a crossover study of eight volunteers, however, Fee et a[lo demonstrated significantly higher plasma levels of diazepam after DPG than after DLE and suggested that the disposition of the drug is somehow affected by its formulation. In our own study we observed in the first ten minutes a significant difference in the degree of sedation produced by the three formulations, this difference being most apparent during the first 6-7 minutes of administration. Over the whole ten-minute period, DPG was ranked significantly more potent that either DMM or DLE and the changing degree of sedation with time suggested there was a lag in the rise to peak effect for DLE.
A possible explanation for these findings is that diazepam is more slowly freed from the lipid emulsion or mixed micelle vehicles than from propylene glycol. It is believed that the area of the solvent particle/plasma interface is of importance in determining the rate of release of the drug from its solvent. 11 The total fat surface area in 1.0 ml of Diazemuls has been estimated to be 6 m 2 and as the diameter of the mixed micelle particle is smaller than the lipid droplet (30 vs 180 angstroms 8 • 12 ) the particle surface area is even greater. This may explain why our results suggested that DLE produced a slower rise in initial sedation.
The major difference between the three preparations occurred between two and seven minutes of administration, at a time when in clinical use, the drugs would be being titrated to effect. It is therefore not surprising that the differences between the preparations would be apparent to the clinician although Figure 1 suggests that these differences become less obvious as time progresses and during the subsequent recovery period no difference was found between the preparations.
The clinical implications of our findings are that when DLE or DMM is used as sedation (e.g. for minor surgical procedures), it is necessary to give higher doses in order to provide the same degree of sedation in the fir~t ten minutes as would be obtained by usmg DPG, although these differences may be less apparent if adequate time (approximately five minutes) is given for the peak effect of each formulation to occur. Because subsequent recovery is not significantly different, it is theoretically possible that the use of higher, initially equipotent doses of the new formulations could result in a delayed recovery.
The differences between the formulations although significant, were also influenced b; subject or testing factors. It was found that with each progressive study day there was a significant rise in the level of sedation achieved during the first ten minutes and a greater degree of psychomotor impairment produced. It is possible that this variation with time could relate either to lessening anxiety levels or reduced subject motivation with each testing session. It is interesting, however, that the variation was consistent both for observer assessment of sedation and in the psychomotor performance battery. It is also possible that a residual effect from diazepam or its long-acting metabolite desmethyldiazepam could account for the differences although this would seem unlikely ~n view of the comparatively long dosing mterval used (three weeks). An alternative pharmacodynamic explanation such as an alteration in benzodiazepine receptor function cannot be ruled out. Whatever the mechanism, it highlights the importance of taking into account the treatment order in the statistical analysis and using a balanced order of treatments in the study design.
Both mixed micelle and lipid emulsion sol v en t systems are significant pharmacological advances. They are successful vehicles for water insoluble drugs, neither appears to exert a pharmacological effect of its own and both have a very low toxicity. For diazepam we have found in this study that changes to solvent systems cause significant alterations to clinical efficacy within the first ten minutes of injection. These alterations to efficacy may, however, be clinically less significant than between-patient variation in pharmacodynamic sensitivity or the conditions under which the drugs are gIven.
